oral semaglutide vs subcutaneous semaglutide Safety of The Semaglutide Pill vs. Injection:

Kim H, Scimia MC, Wilkinson D, Trelles RD, Wood MR, Bowtell D, et al

Contact your GP or healthcare provider within 24 hours if you experience: New or persistent abdominal pain in the right upper quadrant or epigastrium lasting more than a few hours Recurrent episodes of abdominal pain, particularly after meals Unexplained nausea and vomiting that differs from your usual GLP-1-related side effects Any yellowing of the skin or whites of the eyes Dark urine or pale-coloured stools Seek immediate medical attention (attend A&E or call 999) if you develop: Severe, unrelenting abdominal pain High fever (temperature above 38C) with abdominal pain Jaundice accompanied by confusion or drowsiness Signs of sepsis, including rapid heartbeat, rapid breathing, or feeling extremely unwell When gallbladder disease is suspected, initial investigations typically include blood tests (full blood count, urea and electrolytes, liver function tests, C-reactive protein, bilirubin, and serum lipase or amylase) and abdominal ultrasonography, which is the first-line imaging modality for detecting gallstones and assessing the gallbladder

Always request COA and third-party testing reports before procurement

Oral semaglutide (Rybelsus) achieved approximately 1013% weight loss in controlled trials, while newer oral tirzepatide formulations are showing comparable or superior results

Ozempic, a form of semaglutide, is an FDA-approved medication specifically for managing type 2 diabetes by mimicking the GLP-1 hormone